Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 523696 | NSE Symbol : | ISIN : INE842B01015 | Industry : Healthcare |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
24-Jan-2025	03-Feb-2025	Quarterly Results	Quarterly Results Fortis Malar Hospitals Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2025 ,inter alia, to consider and approve the Un-audited Financial Results (Standalone and Consolidated) for the quarter and period ended December 31, 2024 Pursuant to the provisions of Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015 ('SEBI Listing Regulations') this is to inform you that the Board of Directors of the Company at its meeting held today i.e. Monday, February 03, 2025, inter-alia, considered and approved the standalone and consolidated unaudited Financial Results for the quarter and period ended December 31, 2024. (As Per BSE Announcement dated on 03.02.2025)
28-Oct-2024	05-Nov-2024	Quarterly Results	Quarterly Results The relevant disclosure is attached for the Outcome of Board Meeting of the Company held on Tuesday, November 5, 2024. (As Per BSE Announcement dated on 05.11.2024)
15-Jul-2024	22-Jul-2024	Quarterly Results	Fortis Malar Hospitals Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/07/2024 inter alia to consider and approve In pursuance of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 notice is hereby given that meeting of the Board of Directors of the Company will be held on Monday July 22 2024 to inter-alia consider and approve the Un-audited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2024. Further in continuation to our reference letter dated June 25 2024 with respect to the Closure of Trading Window it is hereby informed that the Trading Window for dealing in the Companys Securities shall remain closed till 48 hours after the announcement of the Financial Results i.e. upto July 24 2024. Outcome of the Board Meeting held on July 22, 2024 Un-Audited Financial Results along with Limited Review Report for the quarter ended June 30, 2024 (As per BSE Announcement Dated on 22/07/2024)
10-May-2024	17-May-2024	Accounts	Fortis Malar Hospitals Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2024 inter alia to consider and approve In pursuance of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday May 17 2024 to inter-alia consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31 2024. Further in continuation to our reference letter FMHL/SEC/MAR2024 dated March 27 2024 with respect to the Closure of Trading Window it is hereby informed that the Trading Window for dealing in the Companys Securities shall remain closed till 48 hours after the announcement of the Financial Results i.e. upto May 19 2024. This is for your information and record please. Pursuant to the provisions of Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015 ('SEBI Listing Regulations') this is to inform you that the Board of Directors of the Company at its meeting held today i.e. May 17, 2024, inter-alia, considered and approved the following matters:- (i) Financial Results (ii) Dividend (iii) Re-appointment of Directors (iv) Appointment of Auditors (v) Appointment of Company Secretary and Compliance officer This is for your information and record please. The Company has changed the management of the Company as per detailed disclosure enclosed. The Company has appointed Company Secretary & Compliance Officer as per detailed disclosure enclosed. The Company has appointed re-appointed Mr. Ravi Rajagopal as Independent Director and Mr. Chandrasekar R. as Whole-Time Director, as per detailed enclosed. The Company has re-appointed statutory auditors of the Company as per detailed disclosure enclosed. (As per BSE Announcement Dated on 17/05/2024)
28-Mar-2024	12-Apr-2024	Interim Dividend	Fortis Malar Hospitals Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/04/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI LODR Regulations 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday April 8 2024 inter-alia to consider and declare interim dividend for the year 2024 to the equity shareholders of the Company. The interim dividend if declared shall be paid to the equity shareholders of the Company whose names appear on the Register of Members of the Company or in the records of the Depositories as beneficial owners of the shares as on Tuesday April 16 2024 which is the Record Date fixed for the purpose. The detailed disclosure is enclosed. In continuation and partial modification to the earlier announcement of the Company under Regulation 29 of the SEBI LODR Regulations, 2015, this is to inform you that the record date for payment of interim dividend, if declared, in its Board Meeting scheduled to be held on April 8, 2024 will be paid to the equity shareholders of the Company whose name appear in the register of members of the Company or in the records of the depositories as beneficial owners of the shares as on Wednesday, April 17, 2024 instead of Tuesday, April 16, 2024. the detailed disclosure is enclosed. . This is to inform you that in continuation of the earlier announcement dated March 28, 2024, the record date for payment of Interim Dividend, if any, declared in the meeting of Board of Directors scheduled to be held on April 8, 2024, shall be April 17, 2024 instead of April 16, 2024, the detailed disclosure is enclosed. (As Per BSE Announcement Dated on 29.03.2024) Fortis Malar Hospitals Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/04/2024 ,inter alia, to consider and approve The Board adjourned the matter for considering the interim dividend has been adjourned to May 12, 2024 (As Per BSE Announcement Dated on 08.04.2024) Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), this is to inform you that the Board of Directors of Fortis Malar Hospitals Limited ('the Company') at their adjourned meeting held today inter-alia considered and approved declaration of Interim Dividend of Rs. 40/- (Rupees Forty only) per equity share of Rs. 10/- each on the entire issued, subscribed and paid-up share capital of the Company of 1,87,41,759 equity shares of the nominal value of Rs. 10/- (Rupees ten only) each. The detailed disclosure enclosed. The Board of Directors of the Company has declared an Interim Dividend today, the detailed disclosure is enclosed. Board of Directors of the Company has declared an Interim Dividend in their meeting held today, the detailed disclosure is enclosed. (As Per BSE Announcement Dated on 12.04.2024)
29-Jan-2024	05-Feb-2024	Quarterly Results	Fortis Malar Hospitals Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2024 inter alia to consider and approve In pursuance of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 notice is hereby given that a meeting of the Board of Directors of the Company will be held on Monday February 5 2024 to inter-alia consider and approve the Un-audited Financial Results (Standalone and Consolidated) for the quarter and period ended December 31 2023. Further in continuation to our reference letter FMHL/SEC/DEC2023 dated December 27 2023 with respect to the Closure of Trading Window it is hereby informed that the Trading Window for dealing in the Companys Securities shall remain closed till 48 hours after the announcement of the Un-audited Financial Results i.e. upto February 7 2024. This is for your information and record please. Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e. February 5, 2024, inter-alia, considered and approved unaudited standalone and consolidated financial results of the Company for the quarter and period ended December 31, 2023 ('Quarterly Results'). Accordingly, please find enclosed standalone and consolidated un-audited financial results along with limited review report given by the Statutory Auditor of the Company for the quarter and period ended on December 31, 2023. Please find the results for quarter ended December 31, 2023 (As per BSE Announcement Dated on 05/02/2024)
30-Oct-2023	06-Nov-2023	Quarterly Results	Fortis Malar Hospitals Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2023 inter alia to consider and approve In pursuance of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 notice is hereby given that a meeting of the Board of Directors of the Company will be held on Monday November 06 2023 to inter-alia consider and approve the Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30 2023. Further in continuation to our reference letter FMHL/SEC/SEP2023 dated September 29 2023 with respect to the Closure of Trading Window it is hereby informed that the Trading Window for dealing in the Companys Securities shall remain closed till 48 hours after the announcement of the Un-audited Financial Results i.e. upto November 08 2023. This is for your information and record please. The Board in its meeting held today i.e. November 6, 2023 approved the Un-audited Financial Results (Standalone & Consolidated basis) for the quarter and period ended September 30, 2023 The Board in its meeting held today i.e. November 6, 2023 approved the un-audited financial results for the quarter and period ended September 30, 2023. (As Per BSE Announcement Dated on 06/11/2023)
26-Jul-2023	02-Aug-2023	Quarterly Results	Fortis Malar Hospitals Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2023 inter alia to consider and approve In pursuance of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 notice is hereby given that a meeting of the Board of Directors of the Company will be held on Wednesday August 02 2023 to inter-alia consider and approve the Un-audited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2023. Further in continuation to our reference letter FMHL/SEC/JUNE2023 dated June 29 2023 with respect to the Closure of Trading Window it is hereby informed that the Trading Window for dealing in the Companys Securities shall remain closed till 48 hours after the announcement of the Un-audited Financial Results i.e. upto August 04 2023. This is for your information and record please. The Board in its meeting held today i.e. August 02, 2023, has approved the Un-audited Financial Results (Standalone & Consolidated basis) for quarter ended June 30, 2023. (As per BSE Announcement Dated on 02/08/2023)
12-May-2023	19-May-2023	Accounts	Fortis Malar Hospitals Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2023 inter alia to consider and approve In pursuance of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday May 19 2023 to inter-alia consider and approve the Audited Financial Results (Standalone and Consolidated) for the year ended March 31 2023. Further in continuation to our reference letter FMHL/SEC/March 2023 dated March 30 2023 with respect to the Closure of Trading Window it is hereby informed that the Trading Window for dealing in the Companys Securities shall remain closed till 48 hours after the announcement of the Financial Results i.e. upto May 21 2023. Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015 (SEBI LODR), this is to inform you that the Board of Directors of the Company at its meeting held today i.e. May 19, 2023, inter-alia, considered and approved: - - Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2023 along with Statement of Assets and Liabilities as on March 31, 2023. M/s B S R & Co. LLP, the Statutory Auditors of the Company have issued Audit Report with an unmodified opinion on the Standalone and Consolidated Financial Statements. Audited Financial Results, Auditors' Report, Statement of Assets & Liabilities and statement on unmodified opinion thereon for the financial year ended March 31, 2023 are enclosed. This is for your information and record please. (As per BSE Announcement Dated on 19/05/2023)
31-Jan-2023	07-Feb-2023	Quarterly Results	Fortis Malar Hospitals Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2023 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 notice is hereby given that a meeting of the Board of Directors of the Company will be held on Tuesday February 07 2023 to inter-alia consider and approve un-audited standalone and consolidated results for the quarter and period ended December 31 2022. Further in continuation to our reference letter FMHL/SEC/DECEMBER2022 dated December 29 2022 with respect to the Closure of Trading Window it is hereby informed that the Trading Window for dealing in the Companys Securities shall remain closed till 48 hours after the announcement of the Financial Results i.e. upto February 09 2022. Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e. February 7, 2023, inter-alia, considered and approved unaudited standalone and consolidated financial results of the Company for the quarter and period ended December 31, 2022 ('Quarterly Results'). The Board Meeting commenced at 1400 Hours and concluded at 1830 Hours. Please find enclosed Quarterly Results along with limited review reports thereon. (As Per BSE Announcement Dated on 07/02/2023)
31-Oct-2022	07-Nov-2022	Quarterly Results	Fortis Malar Hospitals Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2022 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 notice is hereby given that a meeting of the Board of Directors of the Company will be held on Monday November 07 2022 to inter-alia consider and approve un-audited standalone and consolidated results for the quarter and half year ended September 30 2022. Further in continuation to our reference letter FMHL/SEC/SEPTEMBER 2022 dated September 29 2022 with respect to the Closure of Trading Window it is hereby informed that the Trading Window for dealing in the Companys Securities shall remain closed till 48 hours after the announcement of the Financial Results i.e. upto November 09 2022. Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e. November 7, 2022, inter-alia, considered and approved unaudited standalone and consolidated financial results of the Company for the quarter and period ended September 30, 2022 ('Quarterly Results'). The Board Meeting commenced at 1400 Hours and concluded at 1700 Hours. Please find enclosed Quarterly Results along with limited review reports thereon. This is for your information and records please. (As Per BSE Announcement Dated on 07.11.2022)
26-Jul-2022	02-Aug-2022	Quarterly Results	Fortis Malar Hospitals Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2022 inter alia to consider and approve un-audited standalone and consolidated results for the quarter ended June 30 2022. Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e. August 2, 2022, inter-alia, considered and approved unaudited standalone and consolidated financial results of the Company for the quarter ended June 30, 2022 ('Quarterly Results'). The Board Meeting commenced at 1400 Hours and concluded at 1725 Hours. Please find enclosed Quarterly Results along with limited review reports thereon. This is for your information and records please. Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e. August 2, 2022, inter-alia, considered and approved unaudited standalone and consolidated financial results of the Company for the quarter ended June 30, 2022 ('Quarterly Results'). The Board Meeting commenced at 1400 Hours and concluded at 1725 Hours. Please find enclosed Quarterly Results along with limited review reports thereon. This is for your information and records please. (As Per BSE Announcement Dated on 02.08.2022)
17-May-2022	24-May-2022	Accounts	Fortis Malar Hospitals Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2022 inter alia to consider and approve Audited Standalone and Consolidated Financial Statements of the Company for the quarter and year ended on March 31 2022. Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015 (SEBI LODR), this is to inform you that the Board of Directors of the Company at its meeting held today i.e. May 24, 2022, inter-alia, considered and approved Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2022 and other matters as mentioned in the disclosure. Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015 (SEBI LODR), this is to inform you that the Board of Directors of the Company at its meeting held today i.e. May 24, 2022, inter-alia, considered and approved Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2022 along with Statement of Assets and Liabilities as on March 31, 2022. Audited Financial Results, Auditors' Report, Statement of Assets & Liabilities and statement on unmodified opinion thereon for the financial year ended March 31, 2022 are enclosed. The Board Meeting commenced at 1415 Hours and concluded at 1935 Hours. This is for your information and records please. (As per BSE Announcement Dated on 24/5/2022)
31-Jan-2022	07-Feb-2022	Quarterly Results	Fortis Malar Hospitals Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2022 inter alia to consider and approve un-audited standalone and consolidated results for the quarter and period ended December 31 2021. Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e. February 7, 2022, inter-alia, considered and approved unaudited standalone and consolidated financial results of the Company for the quarter and period ended December 31, 2021 ('Quarterly Results'). The Board Meeting commenced at 1400 Hours and concluded at 1800 Hours. Please find enclosed Quarterly Results along with limited review reports thereon. This is for your information and records please. (As Per BSE Announcement dated on 07.02.2022)
11-Jan-2022	11-Jan-2022	Change in Directors	Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e. January 11, 2022, inter-alia, considered and approved appointment of Mr. Chandrasekar Ramasamy (DIN: 09414564) as Whole Time Director and Key Managerial Personnel of the Company w.e.f. January 11, 2021. There is no inter-se relationship between Mr. Chandrasekar, other Directors and Key Managerial Personnel and he has declared that, he is not debarred from accessing the capital markets and / or restrained from holding any position / office of director in a company pursuant to order of SEBI or any other such authority. The Board Meeting commenced at 1250 Hours and concluded at 1330 Hours. This is for your information and records please.

1 2

LOGIN HERE

Fortis Malar Hospitals Ltd

Board Meeting